期 |
栏目 |
标题 |
文件 |
卷 83, 编号 5 (2011) |
Editorial |
Ten-year risk of cardiovascular complications in patients with rheumatoid arthritis |
|
卷 83, 编号 5 (2011) |
Editorial |
Current knowledge about pathogenesis and treatment of arterial hypertension in rheumatoid arthritis |
|
卷 84, 编号 5 (2012) |
Editorial |
TOCILIZUMAB IMPACT ON BLOOD CHOLESTERINE TRANSPORT AND EARLY MANIFESTATION OF ATHEROSCLEROSIS IN PATIENTS WITH RHEUMATOID ARTHRITIS |
|
卷 90, 编号 5 (2018) |
Editorial |
Atherosclerosis: perspectives of anti-inflammatory therapy |
(Rus)
|
卷 91, 编号 5 (2019) |
Editorial |
Level of N-terminal fragment of brain natriuretic peptide progenitor and atherosclerotic damage of brachocephalic arteries in patients with rheumatoid arthritis with inefficiency and/or injurability of basic anti - inflammatory treatment |
(Rus)
|
卷 93, 编号 5 (2021) |
Original articles |
Application of cardiovascular risk scales to identify carotid atherosclerosis in patients with rheumatoid arthritis |
(Rus)
|
卷 94, 编号 8 (2022) |
GUIDELINES |
Epithelial protective therapy in comorbid diseases. Practical Guidelines for Physicians |
(Rus)
|
卷 95, 编号 5 (2023) |
Editorial |
Systemic lupus erythematosus and antiphospholipid syndrome: past, present, future |
(Rus)
|
卷 95, 编号 5 (2023) |
Original articles |
Subclinical atherosclerosis of the carotid arteries in patients with rheumatoid arthritis with low cardiovascular risk |
(Rus)
|
卷 96, 编号 5 (2024) |
Original articles |
The effect of hypothyroidism on cardiovascular events and type 2 diabetes mellitus developing in rheumatoid arthritis |
(Rus)
|